» Authors » P Lahdenne

P Lahdenne

Explore the profile of P Lahdenne including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 762
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Boom V, Anton J, Lahdenne P, Quartier P, Ravelli A, Wulffraat N, et al.
Pediatr Rheumatol Online J . 2015 Dec; 13:55. PMID: 26634252
Background: Macrophage activation syndrome (MAS) is a severe and potentially lethal complication of several inflammatory diseases but seems particularly linked to systemic juvenile idiopathic arthritis (sJIA). Standardized diagnostic and treatment...
2.
Markula-Patjas K, Valta H, Pekkinen M, Andersson S, Aalto K, Lahdenne P, et al.
Clin Exp Rheumatol . 2015 Aug; 33(6):924-30. PMID: 26315132
Objectives: The aim of this cross-sectional study was to explore body composition, and the relationship of serum adipokines with bone mass and disease activity, in a cohort of JIA patients...
3.
Hero M, Suomalainen A, Hagstrom J, Stoor P, Kontio R, Alapulli H, et al.
Bone . 2012 Oct; 52(1):347-53. PMID: 23069372
Cherubism is a rare and disfiguring genetic disorder with excessive bone resorption and multilocular lesions in the mandible and/or maxilla. The disease-causing gain-of-function mutations in the SH3-binding protein 2 (SH3BP2)...
4.
Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, et al.
Ann Rheum Dis . 2012 Jan; 71(7):1122-7. PMID: 22258487
Objective: To compare the juvenile arthritis disease activity score (JADAS) based on C reactive protein (CRP) (JADAS-CRP) with JADAS based on erythrocyte sedimentation rate (ESR) (JADAS-ESR) and to validate JADAS...
5.
Tarkiainen M, Tynjala P, Vahasalo P, Lahdenne P
Scand J Rheumatol . 2010 Sep; 40(2):150-2. PMID: 20868307
No abstract available.
6.
Lahdenne P, Wikstrom A, Aalto K, Kolho K
Arthritis Care Res (Hoboken) . 2010 Jun; 62(6):785-90. PMID: 20535789
Objective: To study whether premedication with an oral antifebrile agent (acetaminophen) and antihistamine (cetirizine) could decrease the frequency of acute infusion reactions in pediatric patients. Methods: All pediatric patients scheduled...
7.
Saarinen J, Lehtonen K, Malkia E, Lahdenne P
Clin Exp Rheumatol . 2008 Nov; 26(5):947-53. PMID: 19032836
Objective: The aim of this study was to measure lower extremity isometric strength in patients with juvenile idiopathic arthritis (JIA) and to evaluate the usefulness of an adjustable dynamometer chair...
8.
Tynjala P, Vahasalo P, Honkanen V, Lahdenne P
Ann Rheum Dis . 2008 May; 68(4):552-7. PMID: 18467515
Objectives: To evaluate drug survival (continuation rates on drug) of anti-tumour necrosis factor (TNF) agents in juvenile idiopathic arthritis (JIA) and predictors for treatment discontinuation. Methods: A retrospective observational study...
9.
Tynjala P, Kotaniemi K, Lindahl P, Latva K, Aalto K, Honkanen V, et al.
Rheumatology (Oxford) . 2008 Feb; 47(3):339-44. PMID: 18238789
Objective: To evaluate the efficacy of adalimumab in juvenile idiopathic arthritis (JIA)-associated uveitis. Methods: Retrospective observational study of 20 patients with JIA and chronic uveitis on adalimumab treatment. The ocular...
10.
Cespedes-Cruz A, Gutierrez-Suarez R, Pistorio A, Ravelli A, Loy A, Murray K, et al.
Ann Rheum Dis . 2007 Sep; 67(3):309-14. PMID: 17875547
Objectives: To examine the change in health-related quality of life (HRQOL) and its determinants in children with juvenile idiopathic arthritis (JIA) treated with methotrexate (MTX). Methods: Patients were extracted from...